Panion in ITF-meeting at EMA
Development of new and unique medicines for animals (and humans) requires a close cooperation with the authorities that in the end will decide on the approval and allow marketing of the product. In Europe, genetically based novel medicines are authorised by application to the European Medicines Agency (EMA), currently located in London. To facilitate the understanding of new ideas and approaches to treatment of diseases, the EMA has established an Innovation Task Force (ITF) which consists of experienced scientific reviewers and persons involved in the assessment and processing of new